Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02854800 · ClinicalTrials.gov registry record · Phase 2
Smoking Cessation & Opioid Dependence Treatment Integration
A Phase 2 study, sponsored by West Virginia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
NCT02854800 is a Phase 2 study that has completed, run by West Virginia University. The registered enrollment target is 74 participants.
The verdict
NCT02854800, a Phase 2 study, has completed, sponsored by West Virginia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
Study Summary
The primary purpose of this study was to examine the feasibility of integrating a smoking cessation intervention for cigarette smokers enrolled in an outpatient program for opioid dependence. The secondary purpose was to compare treatment effects as a function of phase in the outpatient program: 0-90 days (weekly attendance), 90 days-1 year (biweekly attendance), and more than 1 year (monthly attendance).
Interventions
- DRUG varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2016-07-08 |
| Est. Completion | 2017-04-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02854800
The ClinicalTrials.gov registry entry for NCT02854800 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which varenicline is the first listed.
NCT02854800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02854800 about?
NCT02854800 is a clinical study titled "Smoking Cessation & Opioid Dependence Treatment Integration". The primary purpose of this study was to examine the feasibility of integrating a smoking cessation intervention for cigarette smokers enrolled in an outpatient program for opioid dependence. The secondary purpose was to compare treatment effects as a function of phase in the outpatient program: 0-9...
What is the current status of trial NCT02854800?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2016-07-08. Estimated completion is 2017-04-10.
What interventions are being tested in trial NCT02854800?
The interventions under investigation include: varenicline (DRUG).
Who is sponsoring clinical trial NCT02854800?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.